Fu, Y., Kang, X., Li, W., Wang, Z., Luo, W., Yang, B., . . . Qin, X. The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapy. Elsevier.
Chicago Style (17th ed.) CitationFu, Yu, et al. The Low-dose CHK1 Inhibitor Prexasertib Triggers VDAC1 Dephosphorylation to Activate MtDNA-STING Signaling and Synergize Immunotherapy. Elsevier.
MLA (9th ed.) CitationFu, Yu, et al. The Low-dose CHK1 Inhibitor Prexasertib Triggers VDAC1 Dephosphorylation to Activate MtDNA-STING Signaling and Synergize Immunotherapy. Elsevier.
Warning: These citations may not always be 100% accurate.